Dwight H. Egan
Known title: Chief Executive OfficerCIK: 0001712187
Associated companies
Transaction History
| CODX | ▲ Buy | Grant | 4,584 | $0 | 5/23/2026 | View on chart |
| CODX | ▼ Sell | Other | 1,633 | $8K | 5/23/2026 | View on chart |
| CODX | ▲ Buy | Grant | 163,333 | $0 | 11/23/2025 | View on chart |
| CODX | ▼ Sell | Other | 49,575 | $17K | 11/23/2025 | View on chart |
| CODX | ▼ Sell | Other | 51,697 | $12K | 5/23/2025 | View on chart |
| CODX | ▲ Buy | Grant | 163,334 | $0 | 5/23/2025 | View on chart |
| CODX | ▲ Buy | Grant | 163,333 | $0 | 11/23/2024 | View on chart |
| CODX | ▼ Sell | Other | 49,689 | $50K | 11/23/2024 | View on chart |
| CODX | ▲ Buy | Grant | 138,333 | $0 | 5/23/2024 | View on chart |
| CODX | ▼ Sell | Other | 42,008 | $46K | 5/23/2024 | View on chart |
| CODX | ▲ Buy | Grant | 150,834 | $0 | 11/23/2023 | View on chart |
| CODX | ▼ Sell | Other | 46,047 | $58K | 11/23/2023 | View on chart |
| CODX | ▼ Sell | Other | 32,103 | $42K | 5/23/2023 | View on chart |
| CODX | ▲ Buy | Grant | 105,000 | $0 | 5/23/2023 | View on chart |
| CODX | ▼ Sell | Other | 32,110 | $111K | 11/23/2022 | View on chart |
| CODX | ▲ Buy | Grant | 79,166 | $0 | 11/23/2022 | View on chart |
| CODX | ▲ Buy | Grant | 33,334 | $0 | 5/23/2022 | View on chart |
| CODX | ▼ Sell | Other | 11,854 | $59K | 5/23/2022 | View on chart |
| CODX | ▼ Sell | Tax Withholding | 15,544 | $131K | 11/23/2021 | View on chart |
| CODX | ▲ Buy | Grant | 33,333 | $0 | 11/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
CODX to Demo Co-Dx PCR Platform and MTB Test at WHX Labs
CODX announced it will show its Co-Dx PCR platform and a new MTB test at WHX Labs. The demo is part of the company’s push to broaden its diagnostic services. It may help the company move toward wider market use of its platform.
CODX to Demo Co-Dx PCR Platform and MTB Test at WHX Labs. CODX announced it will show its Co-Dx PCR platform and a new MTB test at WHX Labs. The demo is part of the company’s push to broaden its diagnostic services. It may help the company move toward wider market use of its platform.